EUCR   $10.04  0.0 Market Closed

Eucrates Biomedical Acquisition Corp
Last Events:

2023-03-30 Trend pattern changed from расширяющаяся формация to восходящий клин.

2023-03-30 Signal in Stochastic changed from bearish to bullish recovery. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.

2023-03-30 Trend changed from linear up to flat and up.

2023-03-29 Trend pattern changed from восходящий клин to расширяющаяся формация.

2023-03-29 Signal in Stochastic changed from bullish recovery to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: signal line crossed the middle level.

2023-03-29 Trend changed from flat and up to linear up.

2023-03-29 Trend pattern changed from расширяющаяся формация to восходящий клин.

2023-03-29 Signal in Stochastic changed from bearish to bullish recovery. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi ActivelyBuy Buy ActivelyBuy
macd - - -
stoch - - -
ma20 - ActivelyBuy ActivelyBuy
ma50 - - -
ma100 ActivelyBuy ActivelyBuy -
Candlestick PatternApril 18, 2023 Gravestone - is formed when the opening and closing prices are at the lowest of the day. If it has a longer upper shadow it signals a bearish trend. When it appears at market top it is considered a reversal signal.
ISIN VGG3141W1068
ceo Mr. Parag Phoolchand Saxena MBA, MS
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.